Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2011-08-24
Summary
The purpose of the study is to describe the regional and global FDG-kinetics in non-small-cell lung cancer (NSCLC) during percutaneous radiation therapy.
Conditions
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Joerg Kotzerke, MD · Department of Nuclear Medicine
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-07-31
Countries
- Germany
Study Locations
More Related Trials
-
The Utility of FDG-PET for Radiation Treatment in NSCLC
NCT00385164 ·Status: UNKNOWN
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
NCT05543954 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
NCT00826033 ·Status: COMPLETED
-
Benefits Study of Respiratory-gated PET Acquisition in Lung Disease
NCT01812031 ·Status: COMPLETED ·Phase: NA
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
NCT00083083 ·Status: UNKNOWN ·Phase: PHASE2
-
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
NCT01610544 ·Status: WITHDRAWN ·Phase: PHASE2
-
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
NCT00004138 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC
NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2
-
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
NCT00464282 ·Status: COMPLETED
-
Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer
NCT01619241 ·Status: UNKNOWN
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
FDG PET/CT in Lung Cancer Staging
NCT02738398 ·Status: COMPLETED ·Phase: NA
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562 ·Status: NOT_YET_RECRUITING
-
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
NCT00721799 ·Status: COMPLETED ·Phase: PHASE2
-
PET Response During Chemoradiation of Lung Cancer
NCT02315053 ·Status: COMPLETED ·Phase: NA
-
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
NCT04151940 ·Status: RECRUITING ·Phase: NA
-
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
NCT00002930 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00847509 ·Status: COMPLETED ·Phase: NA
-
Role of FDG PET, Immune and Hypoxic Marker in NSCLC
NCT02519062 ·Status: COMPLETED